MedTrace Logo

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23

NCT01845090 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-05-03

No results posted yet for this study

Summary

To compare the effect of lanthanum carbonate with calcium carbonate on serum FGF23 levels in hemodialysis patients.

Conditions

  • Other Nonspecific Abnormal Serum Enzyme Levels

Interventions

DRUG

Lanthanum carbonate

the effect on serum FGF23

DRUG

Calcium Carbonate

Calcium carbonate 500mg\~1000 mg tid for 6 months

Sponsors & Collaborators

  • Camillians Saint Mary's Hospital Luodong

    lead OTHER

Principal Investigators

  • Shih-Ching Tsai, MD · Saint Mary's hospital-Lotung

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01845090 on ClinicalTrials.gov